Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.7995
Delayed Data
As of Feb 27
 -0.0005 / -0.06%
Today’s Change
0.65
Today|||52-Week Range
1.52
+14.21%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.80
Today’s open0.80
Day’s range0.77 - 0.82
Volume630,749
Average volume (3 months)1,048,495
Market cap$142.6M
Dividend yield--
Data as of 4:02pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-16.67%
Earnings growth (this year)-42.86%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book9.30

Competitors

 Today’s
change
Today’s
% change
RDHLRedhill Biopharma Lt...+0.12+0.85%
DSCODiscovery Laboratori...-0.02-1.23%
SNSSSunesis Pharmaceutic...0.000.00%
BLPHBellerophon Therapeu...+0.55+4.80%
Data as of 3:59pm ET, 02/27/2015

Financials

Next reporting dateMarch 23, 2015
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$0.00
Annual profit (last year)-$9.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientist
Chang Ho Ahn
Chief Executive Officer &
Director
Peter David Suzdak
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account